Deborah A. Williamson
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Microbiology top 0.2%
- Reproductive tract infections research
Papers in
- Microbiology 62
- Reproductive tract infections research 58
-
- Antimicrobial Resistance in Staphylococcus 43
- SARS-CoV-2 and COVID-19 Research 21
- SARS-CoV-2 detection and testing 16
- Co-authors
- Benjamin P. HowdenGlen P. CarterMarcus Y. ChenChristopher K. FairleyDavid L. PatersonEric P. F. ChowSally RobertsMichael G. Baker
- Journals
- Sexually Transmitted Infections (15 papers)The Medical Journal of Australia (12 papers)Journal of Clinical Microbiology (10 papers)Clinical Infectious Diseases (9 papers)Antimicrobial Agents and Chemotherapy (9 papers)
- Partner nations
- AustraliaNew ZealandUnited Kingdom
In The Last Decade
Deborah A. Williamson
267 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 181
- Molecular Medicine 775
- Microbiology 901
- Endocrinology 591
- Infectious Diseases 2.1k
- Applied Microbiology and Biotechnology 195
Countries citing papers authored by Deborah A. Williamson
This map shows the geographic impact of Deborah A. Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Williamson more than expected).
Fields of papers citing papers by Deborah A. Williamson
This network shows the impact of papers produced by Deborah A. Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Williamson. The network helps show where Deborah A. Williamson may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah A. Williamson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 24 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 34 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 38 | |
| 13 | 2020 | 22 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 10 | |
| 16 | 2019 | 65 | |
| 17 | 2019 | 20 | |
| 18 | 2019 | 16 | |
| 19 | Prevalence of hepatitis E virus antibodies and infection in New Zealand blood donors. | 2018 | 18 |
| 20 | 2016 | 29 |
About Deborah A. Williamson
Deborah A. Williamson is a scholar working on Microbiology, Infectious Diseases, Molecular Medicine, Endocrinology and Virology, having authored 274 papers that have together received 6.3k indexed citations. Recurring topics across this work include Reproductive tract infections research (58 papers), Syphilis Diagnosis and Treatment (44 papers), Antimicrobial Resistance in Staphylococcus (43 papers), Streptococcal Infections and Treatments (37 papers), Antibiotic Resistance in Bacteria (26 papers), SARS-CoV-2 and COVID-19 Research (21 papers), Bacterial Identification and Susceptibility Testing (19 papers) and SARS-CoV-2 detection and testing (16 papers). The work is most often cited by research in Molecular Medicine (775 citations), Microbiology (901 citations), Endocrinology (591 citations), Infectious Diseases (2.1k citations) and Applied Microbiology and Biotechnology (195 citations). Deborah A. Williamson has collaborated with scholars based in Australia, New Zealand and United Kingdom. Frequent co-authors include Benjamin P. Howden, Glen P. Carter, Marcus Y. Chen, Christopher K. Fairley, David L. Paterson, Eric P. F. Chow, Sally Roberts, Michael G. Baker, Nicole J. Moreland and Torsten Seemann. Their work appears in journals such as Sexually Transmitted Infections, The Medical Journal of Australia, Journal of Clinical Microbiology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.